Press Releases :: VolitionRx Ltd (VNRX)

Feb 4, 2016 7:00 am EST

/C O R R E C T I O N -- VolitionRx Ltd/

Feb 4, 2016 7:00 am EST

VolitionRx and Cancer Survivor Sean Swarner Celebrate World Cancer Day with Message of Hope for Cancer Survival Through Early Detection

Feb 2, 2016 7:00 am EST

VolitionRx Initiates Prostate Cancer Study in Collaboration with the Surrey Cancer Research Institute, University of Surrey, UK

Jan 28, 2016 7:00 am EST

VolitionRx Receives International ISO Certification for Quality Management System of its NuQ(R) Blood Tests

Jan 13, 2016 7:00 am EST

VolitionRx Releases Annual Shareholder Update Letter

Jan 5, 2016 7:00 am EST

VolitionRx Announces Dr. Jason Terrell's Transition to Full-Time Status as Chief Medical Officer and Head of U.S. Operations

Jan 4, 2016 7:00 am EST

VolitionRx Granted Its Third U.S. Patent

Dec 8, 2015 7:00 am EST

VolitionRx Demonstrates More Than 90% Accuracy for Colorectal Cancer NuQ(R) Blood Test in Completed Prospective Study

Nov 30, 2015 7:00 am EST

VolitionRx to Present at LD Micro Conference on December 3 in Los Angeles

Nov 19, 2015 7:00 am EST

VolitionRx Demonstrates NuQ® Blood Test Detects Lung Cancers with more than 90% Accuracy

rss_feed News RSS